Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(13%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
1
7%
Ph phase_2
2
13%
Ph phase_3
1
7%
Ph not_applicable
4
27%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(3)
Terminated(1)
Other(6)

Detailed Status

unknown3
Suspended3
Completed3
Not yet recruiting2
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 31 (12.5%)
N/A4 (50.0%)

Trials by Status

unknown320%
enrolling_by_invitation17%
active_not_recruiting17%
not_yet_recruiting213%
recruiting17%
suspended320%
terminated17%
completed320%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT05547347

Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer

Suspended
NCT07277738Not Applicable

Precision Supplemental Imaging in Women With Dense Breasts

Not Yet Recruiting
NCT06671912Phase 3

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial

Suspended
NCT07434128Phase 2

Mammogram Pretreatment With Ulipristal Acetate

Not Yet Recruiting
NCT05989828Phase 1

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Suspended
NCT03672331Not Applicable

My Personalized Breast Screening

Active Not Recruiting
NCT05919108Phase 2

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Recruiting
NCT04761055Not Applicable

Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

Completed
NCT07056686

Early Detection of Breast Cancer Among Syrian Women

Enrolling By Invitation
NCT05305963

Breast CANcer Risk Assessment in Younger Women: BCAN-RAY

Unknown
NCT02681120

Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer

Completed
NCT04034953Not Applicable

Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong

Unknown
NCT00896636

Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration

Unknown
NCT00165412

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Completed
NCT00925405

Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

Terminated

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15